# US 2016/0244723 A1 · Cardiac stem cells and uses of same in cardiac repair

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0244723 A1
- Document ID: US20160244723A1
- Status: Published application
- Kind: A1
- Application number: 14/990,592
- Filed: 2016-01-07
- Published: 2016-08-25
- Earliest claimed: 2003-07-31
- Assignees: Universita' Degli Studi Di Roma “La Sapienza”
- Applicants: Universita degli Studi di Roma "La Sapienza"
- Inventors: Alessandro Giacomello; Elisa Messina; Massimo Battaglia; Giacomo Frati
- Web page: https://patentgrep.com/patent/US20160244723A1

## CPC

- C12N 5/0657: {Cardiomyocytes; Heart cells}
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C12N 5/069: {Vascular Endothelial cells}
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/115: Basic fibroblast growth factor (bFGF, FGF-2)
- C12N 2501/175: Cardiotrophin
- C12N 2533/32: Polylysine, polyornithine
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Method for the isolation, expansion and preservation of cardiac stem cells from human or animal tissue biopsy samples to be employed in cell transplantation and functional repair of the myocardium or other organs. Cells may also be used in gene therapy for treating cardiomyopathies, for treating ischemic heart diseases and for setting in vitro models to study drugs.

## Claims

### Claim 1

A procedure to obtain cardiospheres able to repair damaged myocardiac tissue, comprising:
a. take a biopsy sample of cardiac tissue and keep it in an appropriate culture medium;
b. treat the specimen under appropriate conditions with mild mechanical, chemical or enzymatic techniques to obtain fragments of the sample size large enough to allow diffusion of nutrients present in the medium;
c. fix the tissue fragments to appropriate solid supports and maintain them in a medium containing serum and/or adequate growth factors;
d. allow the cells to grow, changing the medium partially or completely, until multicellular structures form that are either weekly adherent or do not adhere to the support;
e. separate these multicellular structures from the rest of the medium;
f. treat the structures by mild dissociation until most of the small phase bright spherical cells detach but maintain their morphologic and functional characteristics;
g. plate the cells on culture substrates treated with polylysine or other agents promoting the adhesion of the culture to the support in a medium containing at least the minimal essential constituents for the growth of mammalian cells;
h. possibly repeat steps d) to g) at least once;
i. select the cells that aggregate in phase bright spheroid formations (cardiospheres);
j. selectively promote the formation of new Cardiospheres by mild dissociation and new formation;
k. selectively cryopreserved the Cardiospheres for use after thawing.
